Johnson & Johnson (JNJ)

Johnson & Johnson is one of the most prestigious and enduring healthcare corporations in the world, renowned for its massive scale and scientific impact. Following a strategic restructuring to spin off its consumer health division (Kenvue), the modern J&J is hyper-focused on high-margin, high-innovation sectors: Pharmaceuticals (Innovative Medicine) and MedTech. The pharmaceutical division develops complex, life-saving therapies across key therapeutic areas including immunology, oncology, neuroscience, and infectious diseases, boasting a deep portfolio of blockbuster drugs like Darzalex and Stelara. Concurrently, J&J's MedTech segment is a global leader in advanced medical devices, providing crucial equipment for orthopedics, surgery, interventional solutions, and vision care. The company leverages advanced robotics and digital integration to modernize operating rooms worldwide. Johnson & Johnson's immense cash flow enables it to heavily fund internal R&D while continuously executing strategic acquisitions to bolster its pipeline. Despite navigating complex legal liabilities, J&J's AAA credit rating, continuous dividend growth for over half a century, and unwavering commitment to advancing human health make it a highly resilient cornerstone of the global healthcare sector.